SCHEMBL20858985

SCHEMBL20858985

COc1cc(/C=C/C(=O)c2c(OC)cc(C)c(C3=CCN(C)CC3)c2O)cc(OC)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
ABCB1 P08183 2/20 0.47
KRAS P01116 5/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 2/20 0.43
FNTA P49354 2/20 0.43
FNTB P49356 2/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 3/20 0.41
LMNA P02545 2/20 0.41
STAT6 P42226 1/20 0.41
TP53 P04637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL744780 0.92 ABCB1 (0.51) CA1CA2ABCB1KRASABCG2
SCHEMBL20858990 0.90 MAPT (0.45) CA1CA2ABCB1ABCG2MAPT
SCHEMBL7028325 0.89 ABCB1 (0.48) CA1CA2ABCB1KRASABCG2
SCHEMBL20858978 0.89 NFKB1 (0.48) ABCB1ABCG2MAPTMEN1KMT2A
SCHEMBL20858956 0.89 MAPT (0.54) ABCB1ATMMAPTTP53HSD17B10
SCHEMBL20858984 0.87 CXCL12 (0.44) CA1CA2ABCB1KRASABCG2
SCHEMBL20858960 0.85 RAB9A (0.45) ABCB1ALDH1A1SMN1; SMN2L3MBTL1MAPT
SCHEMBL20858983 0.85 ABCB1 (0.50) ABCB1KRASABCG2L3MBTL1MAPT
SCHEMBL20858982 0.85 ABCB1 (0.48) ABCB1ABCG2MAPT
SCHEMBL20858996 0.85 ABCB1 (0.51) ABCB1ABCG2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2429292-B1 COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER GEORGIA STATE UNIV RESEARCH FOUNDATION (US) 2019-04-03 EP disclosed